| Mountain Comprehensive Health Corporation | |
|
185 Circle Dr Ste A Whitesburg KY 41858-7662 | |
| (606) 633-4823 | |
| (606) 633-1874 |
| Full Name | Mountain Comprehensive Health Corporation |
|---|---|
| Speciality | Clinic/Center |
| Location | 185 Circle Dr Ste A, Whitesburg, Kentucky |
| Authorized Official Name and Position | L.m. (mike) Caudill (CEO) |
| Authorized Official Contact | 6066334823 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mountain Comprehensive Health Corporation Po Box 40 Whitesburg KY 41858-0040 Ph: (606) 633-4823 | Mountain Comprehensive Health Corporation 185 Circle Dr Ste A Whitesburg KY 41858-7662 Ph: (606) 633-4823 |
| NPI Number | 1003164203 |
|---|---|
| Provider Enumeration Date | 08/17/2012 |
| Last Update Date | 06/29/2021 |
| Medicare PECOS PAC ID | 7618875873 |
|---|---|
| Medicare Enrollment ID | O20121228000086 |
News Archive
Adlyfe, Inc., a privately held biotech company headquartered in Rockville, MD, focused on early diagnostics for animal and human brain diseases announced the award today of a $650,000 two year grant from the Department of Environment, Food and Rural Affairs (DEFRA) in the UK for continued development of a sensitive early blood test for animal prion diseases.
At the Experimental Nuclear Magnetic Resonance Conference (ENC) 2012, Bruker introduces the novel AVANCE III HD NMR spectrometer.
Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) with or without VELCADE® (bortezomib) for Injection for patients with a common type of lymphoma. The study will examine previously untreated patients with a genomically defined subtype of lymphoma called non-germinal center B-cell-like (non-GCB) diffuse large B-cell lymphoma.
Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration approved the daily pill Tarceva® (erlotinib) as a maintenance treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.
Researchers at St. Michael's Hospital have identified a potential new cause for unexplained miscarriages in mice.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003164203 | NPI | - | NPPES |
News Archive
Adlyfe, Inc., a privately held biotech company headquartered in Rockville, MD, focused on early diagnostics for animal and human brain diseases announced the award today of a $650,000 two year grant from the Department of Environment, Food and Rural Affairs (DEFRA) in the UK for continued development of a sensitive early blood test for animal prion diseases.
At the Experimental Nuclear Magnetic Resonance Conference (ENC) 2012, Bruker introduces the novel AVANCE III HD NMR spectrometer.
Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) with or without VELCADE® (bortezomib) for Injection for patients with a common type of lymphoma. The study will examine previously untreated patients with a genomically defined subtype of lymphoma called non-germinal center B-cell-like (non-GCB) diffuse large B-cell lymphoma.
Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration approved the daily pill Tarceva® (erlotinib) as a maintenance treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.
Researchers at St. Michael's Hospital have identified a potential new cause for unexplained miscarriages in mice.
› Verified 4 days ago
Mountain Comprehensive Health Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 324 Medical Plaza Ln, Whitesburg, KY 41858 Phone: 606-633-6074 | |
Arh Whitesburg Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 214 Hospital Rd, Whitesburg, KY 41858 Phone: 606-633-3631 Fax: 606-633-6204 | |
Arh Whitesburg Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 214 Hospital Rd, Whitesburg, KY 41858 Phone: 606-633-3631 Fax: 606-633-6204 | |
Primary Care Centers Of Eastern Kentucky, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 47 Highway 119 S, Whitesburg, KY 41858 Phone: 606-439-1300 Fax: 606-439-1400 | |
Arh Primary Care Associates Gn Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 47 Highway 119 S Ste 3, Whitesburg, KY 41858 Phone: 606-633-7000 Fax: 606-633-7001 | |
Collins Rural Health Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 109 E Main St, Whitesburg, KY 41858 Phone: 606-633-4488 Fax: 606-633-8383 |